EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Systemic gene therapy corrects the neurological phenotype in a mouse model of NGLY1 deficiency

Ailing Du, Kun Yang, Xuntao Zhou, Lingzhi Ren, Nan Liu, Chen Zhou, Jialing Liang, Nan Yan, Guangping Gao, Dan Wang

JCI Insight · 2024

DOI: 10.1172/jci.insight.183189 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCI Insight, 2024. Verfasst von Ailing Du und 9 weiteren Autor:innen. Beteiligte Einrichtung: Horae Gene Therapy Center, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA. Hauptthemen laut MEDLINE: Genetic Therapy, Disease Models, Animal, Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase, Dependovirus. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIAID NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The cytoplasmic peptide:N-glycanase (NGLY1) is ubiquitously expressed and functions as a de-N-glycosylating enzyme that degrades misfolded N-glycosylated proteins. NGLY1 deficiency due to biallelic loss-of-function NGLY1 variants is an ultrarare autosomal recessive deglycosylation disorder with multisystemic involvement; the neurological manifestations represent the main disease burden. Currently, there is no treatment for this disease. To develop a gene therapy, we first characterized a tamoxifen-inducible Ngly1-knockout (iNgly1) C57BL/6J mouse model, which exhibited symptoms recapitulating human disease, including elevation of the biomarker GlcNAc-Asn, motor deficits, kyphosis, Purkinje cell loss, and gait abnormalities. We packaged a codon-optimized human NGLY1 transgene cassette into 2 adeno-associated virus (AAV) capsids, AAV9 and AAV.PHPeB. Systemic administration of the AAV.PHPeB vector to symptomatic iNgly1 mice corrected multiple disease features at 8 weeks after treatment. Furthermore, another cohort of AAV.PHPeB-treated iNgly1 mice were monitored over a year and showed near-complete normalization of the neurological aspects of the disease phenotype, demonstrating the durability of gene therapy. Our data suggested that brain-directed NGLY1 gene replacement via systemic delivery is a promising therapeutic strategy for NGLY1 deficiency. Although the superior CNS tropism of AAV.PHPeB vector does not translate to primates, emerging AAV capsids with enhanced primate CNS tropism will enable future translational studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TherapyDisease Models, AnimalPeptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine AmidaseDependovirusCongenital Disorders of GlycosylationPhenotypeMice, Inbred C57BLMice, KnockoutAnimalsMiceHumansGenetic Vectors

Stichwörter der Autor:innen

Gene therapyNeurodegenerationNeurological disordersNeuroscienceTherapeutics

Substanzen

Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine AmidaseNGLY1 protein, human

Autor:innen und Institutionen

  • Horae Gene Therapy Center, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
  • Department of Immunology and.
  • Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Department of Microbiology and Physiological Systems and.
  • RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.

Förderung

  • NHLBI NIH HHS
  • NIAID NIH HHS
  • NINDS NIH HHS

Zitieren

APA

Du, A., Yang, K., Zhou, X., Ren, L., Liu, N., Zhou, C., Liang, J., Yan, N., Gao, G., & Wang, D. (2024). Systemic gene therapy corrects the neurological phenotype in a mouse model of NGLY1 deficiency. JCI Insight. https://doi.org/10.1172/jci.insight.183189

Vancouver

Du A, Yang K, Zhou X, Ren L, Liu N, Zhou C, et al. Systemic gene therapy corrects the neurological phenotype in a mouse model of NGLY1 deficiency. JCI Insight. 2024. doi:10.1172/jci.insight.183189

BibTeX
@article{Du2024,
  author = {Du, Ailing and Yang, Kun and Zhou, Xuntao and Ren, Lingzhi and Liu, Nan and Zhou, Chen and Liang, Jialing and Yan, Nan and Gao, Guangping and Wang, Dan},
  title = {Systemic gene therapy corrects the neurological phenotype in a mouse model of NGLY1 deficiency},
  journal = {JCI Insight},
  year = {2024},
  doi = {10.1172/jci.insight.183189}
}
Kostenlos starten →